Latest news
Full year results 2024: portfolio makes good progress in challenging conditions
Commercial and financial developments during the year mean our portfolio is now a mix of companies at different stages of maturity. There was also strong technical progress across the portfolio. Despite the difficult funding environment, four companies raised money during the period and post the year end. We continued to strengthen management teams.
Read moreWatch: The Vaccine Group CEO Dr Jeremy Salt on £400,000 Innovate UK grant for animal health
Dr Jeremy Salt talks about how The Vaccine Group will work with the Animal and Plant Health Agency to develop novel vaccines to combat cattle diseases. He also touches on future developments.
Read moreTVG collaboration with UK government agency awarded £400,000 by Innovate UK
The Vaccine Group and The Animal and Plant Health Agency will use the Smart grant money to develop cattle vaccines based on TVG’s innovative technology.
Read moreOur portfolio
Our portfolio companies are involved in developing a wide range of technologies based on cutting-edge intellectual property to meet the needs and demands of the world.
See all companiesDeakinBio
DeakinBio has developed a technology, termed BioSintering®, to produce advanced bio-based materials from organic waste such as chickpea broth or algae, along with widely available inorganic powders such as crushed limestone.
Learn moreShare price
Share Price InformationLatest downloads
Final results for the year to June 2024
